| [1] |
National Cancer Institute.SEER cancer statistics review,1975-2010[Z]. 2013.
|
| [2] |
OKUDA T,YAMAMOTO S,MATSUO S,et al.Metastasis of pregnancy-associated breast cancer(suspected to be hereditary breast and ovarian cancer) to the brain,diagnosed at 18 weeks' gestation:a case report and review of the literature[J]. Case Rep Obstet Gynecol,2016,2016:9813253.
|
| [3] |
TONIN P,WEBER B,OFFIT K,et al.Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families[J]. Nat Med,1996,2(11):1179-1183.
|
| [4] |
PHELAN C M,KWAN E,JACK E,et al.A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families[J]. Hum Mutat,2002,20(5):352-357.
|
| [5] |
SMITH E C.An overview of hereditary breast and ovarian cancer syndrome[J]. J Midwifery Womens Health,2012,57(6):577-584.
|
| [6] |
RICHARDS S,AZIZ N,BALE S,et al.Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med,2015,17(5):405-424.
|
| [7] |
SURYAVANSHI M,KUMAR D,PANIGRAHI M K,et al.Detection of false positive mutations in BRCA gene by next generation sequencing[J]. Fam Cancer,2017,16(3):311-317.
|
| [8] |
KOZAREWA I,NING Z,QUAIL M A,et al.Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of(G+C)-biased genomes[J]. Nat Methods,2009,6(4):291-295.
|
| [9] |
SUTER N M,RAY R M,HU Y W,et al.BRCA1 and BRCA2 mutations in women from Shanghai China[J]. Cancer Epidemiol Biomarkers Prev,2004,13(2):181-189.
|
| [10] |
LUBINSKI J,PHELAN C M,GHADIRIAN P,et al.Cancer variation associated with the position of the mutation in the BRCA2 gene[J]. Fam Cancer,2004,3(1):1-10.
|
| [11] |
LIEDE A,MALIK I A,AZIZ Z,et al.Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan[J]. Am J Hum Genet,2002,71(3):595-606.
|
| [12] |
MERIC-BERNSTAM F,BRUSCO L,DANIELS M,et al.Incidental germline variants in 1 000 advanced cancers on a prospective somatic genomic profiling protocol[J]. Ann Oncol,2016,27(5):795-800.
|
| [13] |
RISCH H A,MCLAUGHLIN J R,COLE D E,et al.Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer[J]. Am J Hum Genet,2001,68(3):700-710.
|
| [14] |
GRANT R C,SELANDER I,CONNOR A A,et al.Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer[J]. Gastroenterology,2015,148(3):556-564.
|
| [15] |
SZABO C,MASIELLO A,RYAN J F,et al.The breast cancer information core:database design,structure,and scope[J]. Hum Mutat,2015,16(2):123-131.
|
| [16] |
ATCHLEY D P,ALBARRACIN C T,LOPEZ A,et al.Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer[J]. J Clin Oncol,2008,26:4282-4288.
|
| [17] |
DALY M B,PILARSKI R,BERRY M,et al.NCCN guidelines insights:genetic/familial high-risk assessment:breast and ovarian,version 2. 2017[J]. J Natl Compr Canc Netw,2017,15(1):9-20.
|
| [18] |
李军改,回天立,李峥,等. 家族性乳腺癌家系成员乳腺癌易感基因突变的研究[J]. 中华乳腺病杂志(电子版),2012,6(6):631-639.
|
| [19] |
阳泽龙,靳彦文,刘晓静,等. 家族性乳腺癌患者及家系成员乳腺癌易感基因携带情况调查[J]. 中华肿瘤防治杂志,2016,23(10):621-626.
|
| [20] |
KWONG A,CHU A T,WU C T,et al.Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history[J]. Fam Cancer,2014,13(3):423-430.
|
